References
Pascual, A. et al. Nat. Neurosci. 11, 755–761 (2008).
Kopra, J. et al. Nat. Neurosci. doi:10.1038/nn.3941 (16 February 2015).
Peng, C. et al. J. Neurosci. 31, 12802–12815 (2011).
Díaz-Castro, B., Pintado, C.O., García-Flores, P., López-Barneo, J. & Piruat, J.I. Mol. Cell. Biol. 32, 3347–3357 (2012).
Macías, D., Fernández-Agüera, M.C., Bonilla-Henao, V. & López-Barneo, J. EMBO Mol. Med. 6, 1577–1592 (2014).
Hu, X. et al. Prog. Neurobiol. 119–120, 60–84 (2014).
Gonzalez-Reyes, L.E.L. et al. Neuron 75, 306–319 (2012).
Uchida, S. et al. Neuron 69, 359–372 (2011).
Hidalgo-Figueroa, M., Bonilla, S., Gutiérrez, F., Pascual, A. & López-Barneo, J. J. Neurosci. 32, 864–872 (2012).
Schlösser, B., Klausa, G., Prime, G. & Ten Bruggencate, G. J. Comp. Neurol. 405, 185–198 (1999).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Pascual, A., López-Barneo, J. Reply to “GDNF is not required for catecholaminergic neuron survival in vivo”. Nat Neurosci 18, 322–323 (2015). https://doi.org/10.1038/nn.3942
Published:
Issue Date:
DOI: https://doi.org/10.1038/nn.3942
- Springer Nature America, Inc.
This article is cited by
-
GDNF/RET signaling in dopamine neurons in vivo
Cell and Tissue Research (2020)
-
Ret is essential to mediate GDNF’s neuroprotective and neuroregenerative effect in a Parkinson disease mouse model
Cell Death & Disease (2016)